Smart automation protects sensitive pharmaceutical products

In pharmaceutical manufacturing, even minor handling errors can damage products and disrupt production. Sensitive biologics such as albumin may lose effectiveness if foaming occurs during transport, while glass vials, ampoules and prefilled syringes can crack, tip or become scratched through excessive pressure or vibration.

As pharmaceutical production lines become faster and more automated, manufacturers increasingly require transport systems capable of moving delicate products without compromising stability, traceability or hygiene standards.

Pressure-free buffering for fragile pharmaceutical products
To address these challenges, FlexLink developed conveyor systems equipped with Multi-lane FIFO (First In, First Out) buffers. The system uses membrane-style brakes and independent sensors to accumulate products without applying physical pressure between units.

Each vial or container moves independently through the line, reducing contact and minimizing the risk of breakage or foaming. This is particularly important for high-value biologics where product loss can significantly increase production costs.

The FIFO buffer system also supports full product traceability throughout the transport process, an essential requirement in regulated pharmaceutical production environments.

Stable transport for syringes and sensitive containers
For unstable products such as prefilled syringes, FlexLink uses wedge conveyor technology. These conveyors transport products vertically or at inclined angles using FDA-approved cleated chains that stabilize each unit during movement.

The system prevents products from tipping or scuffing while maintaining label readability and handling consistency across different production speeds.

Cleanroom-compatible design reduces contamination risks
All FlexLink pharmaceutical conveyor systems are designed for cleanroom compatibility. Stainless steel construction, smooth surfaces and minimized retention zones simplify cleaning procedures and support compliance with FDA and GMP requirements.

The hygienic design also helps manufacturers reduce downtime associated with cleaning and sanitation processes.

Integrated monitoring supports predictive maintenance
In addition to mechanical handling performance, FlexLink integrated digital monitoring functions into its conveyor systems. Real-time monitoring, automated alerts and predictive maintenance functions allow operators to monitor production performance continuously and identify potential failures before unplanned downtime occurs.

This digital integration also supports production line optimization and operational efficiency improvements.

Compact systems improve space utilization
Space constraints remain a major challenge in pharmaceutical production facilities. FlexLink therefore designed its conveyor systems to minimize installation footprint while maintaining throughput capacity.

According to the company, compact wedge conveyors can reduce footprint requirements by approximately 40 percent compared with conventional elevator systems.

The company also states that its FIFO buffer systems provide zero-pressure accumulation to protect fragile containers and biologic products during transport.

Modular automation tailored to pharmaceutical requirements
FlexLink positions its systems as modular solutions that can be adapted to specific pharmaceutical production challenges, including foaming risks, glass breakage and label protection requirements.

The company’s systems are already used by pharmaceutical manufacturers requiring reliable product transport combined with hygienic operation and digital process visibility.

By combining pressure-free handling, compact equipment design and integrated monitoring functions, the systems are intended to support increasing pharmaceutical production requirements while minimizing product damage and operational interruptions.

Edited by Sucithra Mani, Induportals editor – adapted by AI.

www.flexlink.com